DAS-OLT试验:右美托咪定对肝移植早期移植物功能障碍影响的随机对照试验设计
BACKGROUND: Perioperative ischemia/reperfusion (I/R) injury during liver transplantation is strongly associated with early allograft dysfunction (EAD), graft loss, and mortality.…
要点
- DEX组麻醉诱导后给予负荷量1 μg/kg(10分钟)后以0.5 μg/kg/h持续输注至手术结束。
- 主要目的为验证DEX能否降低肝移植后EAD和PNF的发生率。
- 同时评估DEX对围术期肾功能和肺功能的影响。
核心结论
- 该试验旨在验证肝移植围术期应用DEX可降低EAD和PNF发生率的假设。
研究设计与样本
- 前瞻性、单中心、随机、平行组设计。
关键数值与推荐
- DEX组:麻醉诱导后给予负荷剂量1 μg/kg(10分钟内),随后持续输注0.5 μg/kg/h至手术结束。
- 安慰剂组:麻醉诱导后给予等容量0.9%生理盐水负荷剂量,随后等容量持续输注至手术结束。
- 两组阿片类、镇静药和肌松药等其他用药一致,按常规临床实践给予。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perioperative ischemia/reperfusion (I/R) injury during liver transplantation is strongly associated with early allograft dysfunction (EAD), graft loss, and mortality. Hepatic I/R injury also causes remote damage to other organs including the renal and pulmonary systems. Dexmedetomidine (DEX), a selective α2-adrenoceptor agonist which is used as an adjuvant to general anesthesia, has been shown in preclinical studies to provide organ protection by ameliorating the effects of I/R injury in a range of tissues (including the liver). However, prospective clinical evidence of any potential benefits in improving outcomes in liver transplantation is lacking. This study aimed to verify the hypothesis that the application of dexmedetomidine during the perioperative period of liver transplantation can reduce the incidence of EAD and primary graft non-function (PNF). At the same time, the effects of dexmedetomidine application on perioperative renal function and lung function were studied. METHODS: This is a prospective, single-center, randomized, parallel-group study. Two hundred participants (18-65 years) scheduled to undergo liver transplantation under general anesthesia will be included in this study. For participants in the treatment group, a loading dose of DEX will be given after induction of anesthesia (1 μg/kg over 10 min) followed by a continuous infusion (0.5 μg/kg /h) until the end of surgery. For participants in the placebo group, an equal volume loading dose of 0.9% saline will be given after the induction of anesthesia followed by an equal volume continuous infusion until the end of surgery. All other supplements, e.g., opioids, sedatives, and muscle relaxant, will be identical in both arms and administered according to routine clinical practice. DISCUSSION: The present trial will examine whether DEX confers organoprotective effects in the liver, in terms of reducing the incidence of EAD and PNF in orthotopic liver transplantation recipients. TRIAL REGISTRATION: ClinicalTrials.gov NCT03770130. Registered on 10 December 2018. https://clinicaltrials.gov/ct2/show/NCT03770130.
引用
- Ni C, Masters J, Zhu L, et al. Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation. Trials. 2020. PMID: 32591004. doi:10.1186/s13063-020-04497-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。